Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Almac expands in U.S. and Europe
by Rick Mullin
November 21, 2016
| A version of this story appeared in
Volume 94, Issue 46
The pharmaceutical services firm Almac is embarking on a $34 million expansion in the U.S. and Europe that should increase its staff by 9% to about 5,000 by the end of next year. The company will spend $25 million to expand its U.S. base near Philadelphia, which houses clinical and analytical service operations. Almac will also spend $6 million to add lab and office space at its global headquarters in Craigavon, Northern Ireland, and $3 million to expand the Arran Chemical plant in Athlone, Ireland, that it acquired last year.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X